Illumina Receives Second Information Request from FTC in Bid for Complete Genomics; BGI Extends its Offer | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina said in a regulatory filing after the close of the market on Thursday that it has received a second request from the US Federal Trade Commission for additional information related to the company’s effort to acquire Complete Genomics.

Separately, BGI-Shenzhen said also on Thursday that it has extended its cash tender offer for Complete Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.